BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Sun Pharma and Philogen Sign Exclusive Agreement for NIDLEGY™ Commercialization in Europe, Australia, and New Zealand

Under the terms of the agreement, Sun Pharma will have exclusive rights to commercialise Nidlegy™ for indications of skin cancers in the territories ...

May 31, 2023 | News

Bristol Myers Squibb receives positive CHMP opinion for Opdivo as neoadjuvant treatment for high-risk non-small cell lung cancer

If approved, Opdivo with chemotherapy would be the first and only neoadjuvant immunotherapy-based option authorized to treat patients with non-sm...

May 29, 2023 | Regulatory

Novo Nordisk and Life Edit Therapeutics collaborate on gene editing therapies for rare and cardiometabolic diseases

Life Edit has the option to a global profit share on one programme. Novo Nordisk will make an equity investment in ElevateBio, Li...

May 29, 2023 | News

Aptamer Group Consortium Wins Eurostars Grant for Prenatal Disease Diagnostic Device

As part of a consortium, Aptamer Group with it’s partners will develop a new medical device for improved non-invasive prenatal testing and the di...

May 23, 2023 | News

WuXi Biologics Receives 2023 ISPE Facility of the Year Award for Operations

The awarded facility includes two manufacturing areas utilizing 6x1KL single-use bioreactors for perfusion and 12x4KL single-use bioreactors for fed-batch,...

May 23, 2023 | News

Proteomedix Agrees to Issue Labcorp Exclusive License for Proclarix® Blood Test to Detect Prostate Cancer

Proteomedix, a Swiss diagnostics company committed to advancing prostate cancer care, announced today that it entered into an agreement for Labcorp, a...

May 22, 2023 | News

Fertilix Successfully Blocks Low-Dose Chemical Damage in Plastic Consumer Products

The study, led by Professor Joel Drevet, examined two common chemicals widely used in the plastic industry: dibutyl phthalate and bisphenol AF. These chemi...

May 19, 2023 | News

GenNext® Technologies Partners with Emery Pharma for Biopharmaceutical Protein Footprinting

Through this partnership, GenNext and Emery Pharma will combine forces to provide best-in-class pharmaceutical functional and structural analysis for allos...

May 18, 2023 | News

SHL Medical and MoonLake Immunotherapeutics collaborate to develop sonelokimab autoinjector

Sonelokimab is MoonLake Immunotherapeutics' investigational anti-IL-17 A/F Nanobody technology designed to more directly target sites of inflammation and p...

May 11, 2023 | News

Vetter Expands Production Capacities and Services Offered at Its Austrian Site

Vetter, a leading global Contract Development and Manufacturing Organization (CDMO), continues to drive the expansion of capacities and services for the pr...

May 09, 2023 | News

Biosynth Further Strengthens Peptide Business with Acquisition of Cambridge Research Biochemicals.

Biosynth, a supplier of critical raw materials to the life science industry, announces today that it has acquired Cambridge Research Biochemicals...

May 09, 2023 | News

Nouscom Reaches Clinical Phase II Using ProBioGen’s AGE1.CR.pIX® Production Platform

Nous-209 has been developed using the Nouscom's viral vector platform, which includes adenoviral and Modified Vaccinia Ankara (MVA) vectors, with MVA vecto...

May 04, 2023 | News

Full-Life Technologies Buys Land in Belgium for Radiopharmaceutical Manufacturing Facility.

"Production capability and capacity, as well as logistics challenges have been major bottlenecks to radiotherapeutic discovery and development," said Phili...

May 04, 2023 | News

MicrofluidX and Immatics working together on automated end-to-end bioprocessing for TCR-T therapies

MicrofluidX, a UK-based provider of next generation bioreactors for cell biology research and cell therapy manufacturing, today announces a joint research ...

May 03, 2023 | News

Stay Connected